S&P 500   4,577.10
DOW   34,639.79
QQQ   389.91
S&P 500   4,577.10
DOW   34,639.79
QQQ   389.91
S&P 500   4,577.10
DOW   34,639.79
QQQ   389.91
S&P 500   4,577.10
DOW   34,639.79
QQQ   389.91
NASDAQ:IOSP

Innospec Stock Forecast, Price & News

$84.03
+2.08 (+2.54%)
(As of 12/2/2021 12:00 AM ET)
Add
Compare
Today's Range
$82.15
$84.58
50-Day Range
$81.20
$94.12
52-Week Range
$81.00
$107.73
Volume
73,962 shs
Average Volume
103,138 shs
Market Capitalization
$2.07 billion
P/E Ratio
22.77
Dividend Yield
1.44%
Beta
1.35
30 days | 90 days | 365 days | Advanced Chart
Receive IOSP News and Ratings via Email

Sign-up to receive the latest news and ratings for Innospec and its competitors with MarketBeat's FREE daily newsletter.


Innospec logo

About Innospec

Innospec, Inc. develops, manufactures, blends, markets and supplies fuel additives, oilfield chemicals, personal care, and other specialty chemicals. It operates through the following segments: Fuel Specialties, Performance Chemicals and Oilfield Services. The Fuel Specialties segment develops, manufactures, blends, markets, and supplies a range of specialty chemical products used as additives to a range of fuels. The Performance Chemicals segment provides technology-based solutions for customer's processes or products focused in the personal care, home care, agrochemical, and mining industries. The Oilfield Services segment develops and markets products to prevent loss of mud in drilling operations, chemical solutions for fracturing, stimulation and completion operations, and products for oil and gas production. The company was founded in 1938 and is headquartered in Englewood, CO.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Chemicals & allied products
Sub-Industry
Specialty Chemicals
Current Symbol
NASDAQ:IOSP
CUSIP
45768S10
Employees
1,900
Year Founded
1938

Sales & Book Value

Annual Sales
$1.19 billion
Cash Flow
$5.98 per share
Book Value
$38.44 per share

Profitability

Net Income
$28.70 million
Pretax Margin
9.47%

Debt

Price-To-Earnings

Miscellaneous

Free Float
24,336,000
Market Cap
$2.07 billion
Optionable
Optionable

Company Calendar

Last Earnings
11/02/2021
Ex-Dividend
11/15/2021
Dividend Payable
11/24/2021
Today
12/03/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
2/15/2022

Social Links


MarketRank

Overall MarketRank

2.83 out of 5 stars

Basic Materials Sector

28th out of 223 stocks

Chemicals & Allied Products Industry

6th out of 20 stocks

Analyst Opinion: 3.5Community Rank: 4.4Dividend Strength: 2.5Insider Behavior: 2.5Valuation: 1.3 5 -4 -3 -2 -1 -












Innospec (NASDAQ:IOSP) Frequently Asked Questions

Is Innospec a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Innospec in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Innospec stock.
View analyst ratings for Innospec
or view top-rated stocks.

How has Innospec's stock price been impacted by COVID-19?

Innospec's stock was trading at $72.47 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, IOSP stock has increased by 16.0% and is now trading at $84.03.
View which stocks have been most impacted by COVID-19
.

Are investors shorting Innospec?

Innospec saw a decline in short interest during the month of November. As of November 15th, there was short interest totaling 182,600 shares, a decline of 52.8% from the October 31st total of 387,000 shares. Based on an average daily volume of 105,900 shares, the short-interest ratio is presently 1.7 days. Approximately 0.8% of the shares of the stock are sold short.
View Innospec's Short Interest
.

When is Innospec's next earnings date?

Innospec is scheduled to release its next quarterly earnings announcement on Tuesday, February 15th 2022.
View our earnings forecast for Innospec
.

How were Innospec's earnings last quarter?

Innospec Inc. (NASDAQ:IOSP) released its earnings results on Tuesday, November, 2nd. The specialty chemicals company reported $1.15 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $1.13 by $0.02. The specialty chemicals company had revenue of $376.10 million for the quarter, compared to the consensus estimate of $358.50 million. Innospec had a trailing twelve-month return on equity of 12.31% and a net margin of 6.65%. During the same quarter in the previous year, the business posted $0.71 EPS.
View Innospec's earnings history
.

How often does Innospec pay dividends? What is the dividend yield for Innospec?

Innospec declared a Semi-Annual dividend on Tuesday, November 2nd. Shareholders of record on Tuesday, November 16th will be paid a dividend of $0.59 per share on Wednesday, November 24th. This represents a dividend yield of 1.3%. The ex-dividend date is Monday, November 15th. This is an increase from Innospec's previous Semi-Annual dividend of $0.57.
View Innospec's dividend history
.

Is Innospec a good dividend stock?

Innospec pays an annual dividend of $1.18 per share and currently has a dividend yield of 1.44%. Innospec does not yet have a strong track record of dividend growth. The dividend payout ratio of Innospec is 31.98%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Innospec will have a dividend payout ratio of 22.91% next year. This indicates that Innospec will be able to sustain or increase its dividend.
View Innospec's dividend history.

What price target have analysts set for IOSP?

1 analysts have issued 1-year price objectives for Innospec's shares. Their forecasts range from $110.00 to $110.00. On average, they expect Innospec's share price to reach $110.00 in the next year. This suggests a possible upside of 30.9% from the stock's current price.
View analysts' price targets for Innospec
or view top-rated stocks among Wall Street analysts.

Who are Innospec's key executives?

Innospec's management team includes the following people:
  • Patrick S. Williams, President, Chief Executive Officer & Director (LinkedIn Profile)
  • Phil Boon, Chief Operating Officer & Executive Vice President
  • Ian Philip Cleminson, Chief Financial Officer & Executive Vice President
  • Ian Malcolm McRobbie, Chief Technology Officer & Senior Vice President
  • David B. Jones, Secretary, Chief Compliance Officer & VP

What is Patrick S. Williams' approval rating as Innospec's CEO?

12 employees have rated Innospec CEO Patrick S. Williams on Glassdoor.com. Patrick S. Williams has an approval rating of 96% among Innospec's employees. This puts Patrick S. Williams in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Innospec own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Innospec investors own include NVIDIA (NVDA), Altria Group (MO), Ecolab (ECL), Eastman Chemical (EMN), Corning (GLW), Realty Income (O), Pfizer (PFE), Sherwin-Williams (SHW), Weyerhaeuser (WY) and Applied Materials (AMAT).

What is Innospec's stock symbol?

Innospec trades on the NASDAQ under the ticker symbol "IOSP."

Who are Innospec's major shareholders?

Innospec's stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (15.81%), Dimensional Fund Advisors LP (4.73%), Alliancebernstein L.P. (3.95%), Janus Henderson Group PLC (3.67%), Wasatch Advisors Inc. (2.26%) and Geode Capital Management LLC (1.82%). Company insiders that own Innospec stock include Brian Watt, Catherine Hessner, Hugh Aldous, Ian Cleminson, Milton C Blackmore and Patrick Williams.
View institutional ownership trends for Innospec
.

Which institutional investors are selling Innospec stock?

IOSP stock was sold by a variety of institutional investors in the last quarter, including Thrivent Financial for Lutherans, BlackRock Inc., Invesco Ltd., Eagle Asset Management Inc., Renaissance Technologies LLC, Tygh Capital Management Inc., Dimensional Fund Advisors LP, and UBS Group AG. Company insiders that have sold Innospec company stock in the last year include Brian Watt, Ian Cleminson, Milton C Blackmore, and Patrick Williams.
View insider buying and selling activity for Innospec
or view top insider-selling stocks.

Which institutional investors are buying Innospec stock?

IOSP stock was purchased by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., Alliancebernstein L.P., Goldman Sachs Group Inc., Millennium Management LLC, Janus Henderson Group PLC, Morgan Stanley, Two Sigma Advisers LP, and Two Sigma Investments LP.
View insider buying and selling activity for Innospec
or or view top insider-buying stocks.

How do I buy shares of Innospec?

Shares of IOSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Innospec's stock price today?

One share of IOSP stock can currently be purchased for approximately $84.03.

How much money does Innospec make?

Innospec has a market capitalization of $2.07 billion and generates $1.19 billion in revenue each year. The specialty chemicals company earns $28.70 million in net income (profit) each year or $3.69 on an earnings per share basis.

How many employees does Innospec have?

Innospec employs 1,900 workers across the globe.

When was Innospec founded?

Innospec was founded in 1938.

What is Innospec's official website?

The official website for Innospec is www.innospecinc.com.

Where are Innospec's headquarters?

How can I contact Innospec?

Innospec's mailing address is 8310 SOUTH VALLEY HIGHWAY SUITE 350, ENGLEWOOD CO, 80112. The specialty chemicals company can be reached via phone at (303) 792-5554, via email at [email protected], or via fax at 303-792-5668.


This page was last updated on 12/3/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.